ACTU analyst estimates
Actuate Therapeutics (ACTU) analyst ratings, the average price target and its range, and every firm's latest call.
- 1 firms rate ACTU: 1 buy, 0 hold, 0 sell.
- The average price target is $21.00 from None analysts, from $21.00 to $21.00.